Trials / Completed
CompletedNCT03189641
Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions
An Exploratory Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- JIMRO Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the this trial is to evaluate the clinical safety and efficacy of Cilostazol eluting stent system (CES-1) for the treatment of single de novo lesions in native coronary arteries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cilostazol eluting stent system (CES-1) | Implantation of drug eluting stent |
Timeline
- Start date
- 2017-05-31
- Primary completion
- 2020-03-27
- Completion
- 2024-07-26
- First posted
- 2017-06-16
- Last updated
- 2025-03-14
Locations
6 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT03189641. Inclusion in this directory is not an endorsement.